Effects of clozapine on sleep measures and sleep-associated changes in growth hormone and cortisol in patients with schizophrenia

Jung H. Lee, Jong I. Woo*, Herbert Y. Meltzer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Abstract

There have been limited reports on the effect of the atypical anti-psychotic agent clozapine on sleep measures and hormone secretion. The goal of this study was to determine the type, rate, and extent of changes in sleep measures and nighttime secretion of growth hormone (GH) and cortisol during clozapine treatment. Five schizophrenic patients (age: 32.4 ± 7.4) and five age- and sex-matched normal subjects (age: 33.0 ± 5.1) underwent nocturnal polysomnography (NPSG) before clozapine therapy (S1), and during early and late clozapine therapy (S2 and S3). Serum GH and cortisol levels were monitored during each NPSG. NPSG findings showed that the mean total sleep time, sleep efficiency, and duration of awakening were increased at S2, and maintained until S3. The mean amounts of stage 2 sleep at S2 and S3 increased significantly compared with that of S1. In unmedicated schizophrenic patients, the mean plasma GH level in rapid eye movement sleep was lower than during the waking stage, and the mean level of plasma cortisol was higher during the waking stage. Plasma cortisol levels did not differ between control subjects and patients at any time, but clozapine treatment decreased plasma cortisol levels at S2 compared with S1 and S3. Plasma GH levels were unchanged by clozapine treatment. Clozapine improved sleep continuity and increased stage 2 sleep time from the beginning of therapy. These effects were maintained through at least 7 weeks of therapy. However, clozapine did not affect the relationship of plasma GH and cortisol levels with sleep stages in schizophrenic patients.

Original languageEnglish (US)
Pages (from-to)157-166
Number of pages10
JournalPsychiatry Research
Volume103
Issue number2-3
DOIs
StatePublished - Sep 20 2001

Funding

This research was partly supported by MH 47818, a grant from the William K. Warren, Jr., Foundation, Mr and Mrs Donald Test, and the Brain Science and Engineering Research Program (Grant No. 97-N1-02-03-A-12) sponsored by the Korean Ministry of Science and Technology. We thank Dr Paul Thompson, Department of Psychiatry, Case Western Reserve University School of Medicine, for assistance in the statistical analysis.

Keywords

  • Atypical anti-psychotic medication
  • Neuroendocrine measures
  • Polysomnography
  • Sleep continuity

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Fingerprint

Dive into the research topics of 'Effects of clozapine on sleep measures and sleep-associated changes in growth hormone and cortisol in patients with schizophrenia'. Together they form a unique fingerprint.

Cite this